Owners, management and financials
CVR: 44212765
Secondary names: metaLead ApS
DKK -1,059,149
Gross profit
Net result: DKK -1,374,975
metaLead Therapeutics AG (100%)
CVR · view owners
Michal Mazal Shoshan
CVR · view management
Active
Founded 2 August 2023
CVR · view overview
1 employee
CVR · 2025
Director role ended: Emilie Déjean
CVR · 06/03/2025
View the full event history
metaLead Therapeutics ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Michal Mazal Shoshan. The company is owned by metaLead Therapeutics AG. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -1,059,149 and a net result of DKK -1,374,975. Equity in the 2025 report amounted to DKK -4,132,623.
Selskabets formål er at håndtere og fremstille lægemiddelkandidater mod giftige metaller.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -1.1 mio. | -1.4 mio. | 336 t. | -4.1 mio. | 1 |
Compared to 1.040 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorThe CVR number of metaLead Therapeutics ApS is 44212765.
metaLead Therapeutics ApS is owned by metaLead Therapeutics AG.
The management of metaLead Therapeutics ApS consists of Michal Mazal Shoshan.
In 2025, metaLead Therapeutics ApS reported a gross profit of DKK -1,059,149.
metaLead Therapeutics ApS had 1 employee in 2025 according to the Danish CVR register.
metaLead Therapeutics ApS was founded on 2 August 2023.
Claim this page to add your logo and social links. Free to get started.
MetaLead Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -1,059,149, and the net result was DKK -1,374,975.
MetaLead Therapeutics ApS has published its interim report for the period August 2, 2023 – December 31, 2024.
As of March 6, 2025, Emilie Déjean has stepped down as director of metaLead Therapeutics ApS.
As of August 2, 2023, Michal Mazal Shoshan is registered as adm. dir. of metaLead Therapeutics ApS.
As of August 2, 2023, Emilie Déjean is registered as director of metaLead Therapeutics ApS.
As of August 2, 2023, is registered as an owner of metaLead Therapeutics ApS with an ownership share of 100%.
MetaLead Therapeutics ApS was founded on August 2, 2023.
Companies in the same industry and area
CVR 43630938
CVR 46201671
CVR 20987545
CVR 56976116
CVR 27886124
